摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-甲基-4-萘-2-基苯酚 | 1261917-24-1

中文名称
2-甲基-4-萘-2-基苯酚
中文别名
——
英文名称
2-Methyl-4-(naphthalen-2-YL)phenol
英文别名
2-methyl-4-naphthalen-2-ylphenol
2-甲基-4-萘-2-基苯酚化学式
CAS
1261917-24-1
化学式
C17H14O
mdl
MFCD18313289
分子量
234.298
InChiKey
YFQUBVZWLRTWCP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    391.0±11.0 °C(Predicted)
  • 密度:
    1.151±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    18
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.058
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

点击查看最新优质反应信息

文献信息

  • Disubstituted lavendustin A analogs and pharmaceutical compositions comprising the analogs
    申请人:THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
    公开号:EP1367046A9
    公开(公告)日:2004-05-12
    Disubstituted lavendustin A analogs that are PTK inhibitors having antiproliferative activity are described. Preferred compounds of the present invention, without limitation, satisfy either Formula 1 or Formula 2. Currently preferred compounds ,based on in vivo biological activity, are 4'-adamantylbenzoate-1'-N-1,4-dihydroxybenzylamine and 4'-adamantylmethylbenzoate-1'-N-1,4-dihydroxybenzylamine. The present invention also provides pharmaceutical compositions comprising effective amounts of disubstituted lavendustin A analogs. Such compositions also may comprise other active ingredients, other materials conventionally used in the formulation of pharmaceutical composition, and mixtures thereof. The compounds and compositions of the present invention can be used for treating subjects to, for example, inhibit the proliferation of living cells in the treatment of proliferative diseases.
    描述了具有抗增殖活性的PTK抑制剂的二取代拉文杜斯汀A类似物。本发明的优选化合物,不受限于,满足Formula 1或Formula 2中的任一种。根据体内生物活性,目前优选的化合物是4'-金刚烷基苯甲酸酯-1'-N-1,4-二羟基苯乙胺和4'-金刚烷基甲基苯甲酸酯-1'-N-1,4-二羟基苯乙胺。本发明还提供了含有二取代拉文杜斯汀A类似物有效量的药物组合物。这种组合物还可以包括其他活性成分、传统用于制备药物组合物的其他材料以及它们的混合物。本发明的化合物和组合物可用于治疗受试者,例如,在治疗增殖性疾病中抑制活细胞的增殖。
  • Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs
    申请人:THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
    公开号:EP1367046A1
    公开(公告)日:2003-12-03
    Disubstituted lavendustin A analogs that are PTK inhibitors having antiproliferative activity are described. Preferred compounds of the present invention, without limitation, satisfy either Formula 1 or Formula 2. Currently preferred compounds ,based on in vivo biological activity, are 4'-adamantylbenzoate-1'-N-1,4-dihydroxybenzylamine and 4'-adamantylmethylbenzoate-1'-N-1,4-dihydroxybenzylamine. The present invention also provides pharmaceutical compositions comprising effective amounts of disubstituted lavendustin A analogs. Such compositions also may comprise other active ingredients, other materials conventionally used in the formulation of pharmaceutical composition, and mixtures thereof. The compounds and compositions of the present invention can be used for treating subjects to, for example, inhibit the proliferation of living cells in the treatment of proliferative diseases.
    本发明描述了具有抗增殖活性的 PTK 抑制剂--二取代的拉芬多汀 A 类似物。本发明的优选化合物不限于满足式 1 或式 2。根据体内生物活性,目前优选的化合物是 4'-金刚烷基苯甲酸-1'-N-1,4-二羟基苄胺和 4'-金刚烷基甲基苯甲酸-1'-N-1,4-二羟基苄胺。本发明还提供了包含有效量的二取代拉芬多汀 A 类似物的药物组合物。此类组合物还可包含其他活性成分、用于配制药物组合物的其他常规材料及其混合物。本发明的化合物和组合物可用于治疗受试者,例如在治疗增殖性疾病时抑制活细胞的增殖。
  • US6943191B1
    申请人:——
    公开号:US6943191B1
    公开(公告)日:2005-09-13
  • 플루오렌닐 트리아진 유도체 유기화합물 및 이를 포함하는 유기 전계 발광 소자
    申请人:CMDL Co.,Ltd. (주)씨엠디엘(120170170502) Corp. No ▼ 161511-0210660BRN ▼171-81-00621
    公开号:KR20180029429A
    公开(公告)日:2018-03-21
    하기 화학식 a로 표시되는 유기 화합물이 제공된다. 003c#화학식 a003e# 상기 식에서, R 내지 R, L, Ar 및 Ar 는 전술하여 정의된 바와 같다.
    提供有机化合物的化学式表示为a。在上述式中,R至R,L,Ar和Ar如前述所定义。
查看更多